Manus Neurodynamica: Edinburgh-based firm secures 1.2 million to launch Parkinson's early warning pen
The device has already passed clinical trials with the NHS and the company is in talks to supply a UK-based primary care group
Read full article »
Manus is a Scotland-based biotechnology company that develops triage devices for physicians to diagnose patients with Parkinson’s disease.
Read more